Merck & Co., Inc. pulled Vioxx, a $2.5 billon a year nonsteroidal anti-inflammatory drug, off the shelf in September 2004. The removal followed a study that was published reporting Vioxx increased the risk of cardiovascular events after long-term use. In the years since then, many lawsuits have...

In June 1997, the American Law Institute adopted the Restatement (Third) of Torts: Products Liability. The restatement attempts to organize, clarify, and restate thirty years of case law decided under a single provision, section 402A of the Restatement (Second) of Torts. Section 402A was itself...